SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

ADARx Pharmaceuticals plans IPO sale of 21.9M shares

ADARx Pharmaceuticals said it plans to sell nearly 21.9 million shares in its IPO at $15 to $17 each.

ABBV

By Colin KellaherADARx Pharmaceuticals on Monday said it plans to sell nearly 21.9 million shares at between $15 and $17 apiece in its initial public offering.At the $16 midpoint of that price range, the San Diego clinical stage biotechnology company said it expects net proceeds of about $318.6 mil…

Related stories